Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/10/20 → 07/5/23 |
Funding
- Pfizer Incorporated: $20,107.20
A Phase 2a, Randomized, Double-Blind, Placebo Controlled Study Investigating the Safety of Ritlecitnib (PF-06651600) in Adult Participants with Alopecia Areata
- Kaufmann, Tara (PI)
- Salvemini, Joann (CoPI)
- Haughton, Adrienne (CoPI)
Project: Research